| E/CN.7/2023/1 |
Provisional agenda, annotations and proposed organization of work |
| E/CN.7/2023/2-E/CN.15/2023/2 |
Report of the Executive Director on the activities of the United Nations Office on Drugs and Crime |
| E/CN.7/2023/3-E/CN.15/2023/3 |
Note by the Secretariat on the work of the standing open-ended working group on improving the governance and financial situation of the United Nations Office on Drugs and Crime |
| E/CN.7/2023/4 |
Report of the Secretariat on the world situation with regard to drug abuse |
| E/CN.7/2023/5 |
Report of the Secretariat on the world situation with regard to drug trafficking |
| E/CN.7/2023/6 |
Note by the Secretariat on promoting coordination and alignment of decisions between the Commission on Narcotic Drugs and the Programme Coordinating Board of the Joint United Nations Programme on HIV/AIDS |
| E/CN.7/2023/7 |
Report of the Secretariat on action taken by the subsidiary bodies of the Commission on Narcotic Drugs |
| E/CN.7/2023/8 |
Note by the Secretariat on changes in the scope of control of substances: proposed scheduling recommendations by the World Health Organization |
| E/CN.7/2023/9 | Report of the Secretariat on strengthening international cooperation in combating illicit opiates originating in Afghanistan through continuous and reinforced support to the Paris Pact initiative |
| E/CN.7/2023/10-E/CN.15/2023/12 | Note by the Secretariat on the proposed programme plan and budget for 2024 and programme performance for 2022 for the United Nations Office on Drugs and Crime |
| E/CN.7/2023/CRP.1 | Chair’s summary on the thematic discussions on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration (21 – 22 September 2022) |
| E/CN.7/2023/CRP.2 | Note by the Secretariat on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration |
| E/CN.7/2023/CRP.3 | Note by the Secretariat on inter-agency cooperation and coordination of efforts in addressing and countering the world drug problem |
| E/CN.7/2023/CRP.4 | Conference room paper submitted by Czechia, titled “Opportunities and Challenges for the Engagement of Civil Society in Human Rights Oriented Drug Policies” |
| E/CN.7/2023/CRP.5 | Changes in the scope of control of substances: proposed scheduling recommendations by the World Health Organization |
| E/CN.7/2023/CRP.6 | Reports by intergovernmental organizations on drug control activities in 2022 |
| E/CN.7/2023/CRP.7 | Conference room paper submitted jointly by Germany, Peru, Thailand, and UNODC titled, “Towards more inclusive Alternative Development |
| E/CN.7/2023/CRP.8 | Conference room paper: A call for action to positively redirect the developmental trajectory of children through “Promoting comprehensive and scientific evidence-based early prevention” |
| E/CN.7/2023/CRP.9 | Conference room paper: The relationship between quality of specialist treatment for substance use disorders and patient outcomes: A scoping review of the literature |
| E/CN.7/2023/CRP.10 | Conference room paper: Review of interventions to treat drug use disorders among girls and women in the criminal justice system in low- and middle-income countries |
| E/CN.7/2023/CRP.11 | Conference room paper submitted by Ghana titled “National Dialogue on the International Guidelines on Human Rights and Drug Policy, held in Accra, Ghana from 12 to 13 December 2022” |
| E/CN.7/2023/CRP.12 | Conference room paper submitted by the Permanent Mission of Belarus, in the country's capacity as Chair of the Collective Security Treaty Organisation in 2023: Statement of the Ministers for Foreign Affairs of the Member States of the Collective Security Treaty Organisation on cooperation in countering the global drug threat, adopted on November 23, 2022 [Russian] |
| E/CN.7/2023/CRP.13 | Conference room paper submitted by Mexico, titled “Compilation of Policy Commitments identified by Mexico, as contained in the three policy documents of 2009, 2014 and 2016” |
| E/CN.7/2023/NGO/1 | Written statement submitted by the African Council on Narcotics |
| E/CN.7/2023/NGO/2 | Written statement submitted by Proyecto Hombre Association |
| E/CN.7/2023/NGO/3 | Written statement submitted by Dianova International |
| E/CN.7/2023/NGO/4 | Written statement submitted by Turkish Green Crescent Society |
| E/CN.7/2023/NGO/5 | Written statement submitted by Liberian United Youth for Community Safety and Development |
| E/CN.7/2023/NGO/6 | Written statement submitted by IDPC Consortium |
| E/CN.7/2023/NGO/7 | Declaración presentada por el Instituto RIA, AC [Spanish] |
| E/CN.7/2023/NGO/8 | Declaración presentada por la Corporación ATS Acción Técnica Social (ATS) [Spanish] |
| E/CN.7/2023/NGO/9 | Written statement submitted by the International Association for Hospice and Palliative Care |
| E/2023/28 - E/CN.7/2023/11 |
Report on the 66th session of the Commission on Narcotic Drugs |
| E/CN.7/2023/CRP.14 |
List of documents before the Commission at its 66th session |
Language |
Title or description |
|
Implementation of all international drug policy commitments: - Ministerial Declaration on Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of Our Joint Commitments to Address and Counter the World Drug Problem" (2019) - Outcome document of the thirtieth special session of the General Assembly, entitled "Our joint commitment to effectively addressing and countering the world drug problem" (2016) - Joint Ministerial Statement of the 2014 High-level Review by the Commission on Narcotic Drugs of the Implementation by Member States of the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem (2014) - Political Declaration and Plan of Action on International Cooperation towards and Integrated and Balanced Strategy to Counter the World Drug Problem (2009) |
